Customize
K2137793D-Side SA · cleared 2022-03-16 · product code QIH · Radiology
Premarket evidence — what FDA accepted
source quote (p.3)
“Customize for shoulder arthroplasty is intended to be used as a software interface to assist in: Visualization, modification, validation of the planning of shoulder arthroplasty Communication of treatment options Segmentation of CT-scan data 3D CAD models generation Managing timeline and cases”
Validation studies (1)
Bench
sample size not stated
endpoints: segmentation validation of the Customize software; Repeatability and Reproducibility study on the segmentation of shoulder anatomies; accuracy study on 3D model generation for humerus and scapula
Reported performance (0 observations)
FDA source did not state a quantitative performance metric — non-reporting is itself the signal.
Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.
Predicate network
Postmarket — what happened after clearance
- re_clearance
The FDA AI/ML device list shows a newer 510(k) K221432 (decision 2022-08-03) from 3D-Side SA for a matching device line ("Customize") — a new clearance for the same line is a change event.
first seen 2026-07-08 · k_number:K221432
Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.
Reimbursement — how devices like this got paid
Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).